Recent advances on the role of CD40 and dendritic cells in immunity and tolerance

Current Opinion in Hematology

Volumn 10, Issue 4, 2003, Pages 272-278

  O'Sullivan, Brendan ^a   Thomas, Ranjeny ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; TRANSCRIPTION FACTOR;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ANTIGEN PRESENTATION; AUTOREGULATION; B LYMPHOCYTE; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MEDIATOR; MONOCYTE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE;

ANTIGENS, CD40; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; IMMUNE SYSTEM; IMMUNE TOLERANCE; SIGNAL TRANSDUCTION;

EID: 0037632776     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200307000-00004     Document Type: Review

References (68)

1. Prilliman KR, Lemmens EE, Palioungas G, et al.: Cutting edge: a crucial rolefor B7-CD28 in transmitting T help from APC to CTL. J Immunol 2002, 169:4094-4097. Demonstrates the role of B7-CD28 signaling in CTL cross-priming.
2. Miller RE, Jones J, Le T, et al.: 4-1 BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner. J Immunol 2002, 169:1792-1800. Shows that 4-1 BB is an important signaling molecule in CTL generation, and shows the potential use of specific mAb in tumor immunotherapy.
3. Wagner DH Jr, Vaitaitis G, Sanderson R, et al.: Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes. Proc Natl Acad Sci U S A 2002, 99:3782-3787.
4. Bourgeois C, Rocha B, Tanchot C: A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory. Science 2002, 297:2060-2063. Shows that CD8+ T cells can receive help directly from CD4+ T cells, which is important in CTL memory generation.
5. Bennett SR, Carbone FR, Karamalis F, et al.: Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998, 393:413-414.
6. Wang Y, Kelly CG, Karttunen JT, et al.: CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity 2001, 15:971-983.
7. Srivastava P: Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 2002, 20:395-425.
8. Binder RJ, Han DK, Srivastava PK: CD91: a receptor for heat shock protein gp96. Nat Immunol 2000, 1:151-155.
9. Basu S, Binder RJ, Ramalingam T, et al.: CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 2001, 14:303-313.
10. Berwin B, Hart JP, Pizzo SV, et al.: Cutting edge: CD91-independent cross-presentation of GRP94(gp96)-associated peptides. J Immunol 2002, 168:4282-4286.
11. Becket T, Hartl FU, Wieland F: CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J Cell Biol 2002, 158:1277-1285. Demonstrates that CD40 binds and internalizes human HSP-70 complexed with peptide, and that this leads to activation of the p38 mitogen-activated protein kinase pathway within the cell. The process is ADP-dependent.
12. Kamath AT, Pooley J, O'Keeffe MA, et al.: The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J Immunol 2000, 165:6762-6770.
13. Vremec D, Pooley J, Hochrein H, et al.: CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J Immunol 2000, 164:2978-2986.
14. Nakano H, Yanagita M, Gunn MD: CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med 2001, 194:1171-1178.
15. Asselin-Paturel C, Boonstra A, Dalod M, et al.: Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2001, 2:1144-1150.
16. del Hoyo GM, Martin P, Vargas HH, et al.: Characterization of a common precursor population for dendritic cells. Nature 2002, 415:1043-1047. Identifies a CD11c+ CD40-low precursor population in mouse blood that gives rise to dendritic cells when adoptively transferred.
17. Schulz O, Edwards DA, Schito M, et al.: CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 2000, 13:453-462.
18. Edwards AD, Manickasingham SP, Sporri R, et al.: Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering. J Immunol 2002, 169:3652-3660. The authors show that CD154 signaling amplifies innate signals for cytokine production by dendritic cells. They provide support for the instructional model of dendritic cell function in that pattern recognition rather than lineage determines the production of cytokines by individual dendritic cell subsets.
19. Turnbull E, MacPherson G: Immunobiology of dendritic cells in the rat. Immunol Rev 2001, 184:58-68.
20. Hochrein H, Shortman K, Vremec D, et al.: Differential production of IL-12, IFN-alpha, and IFN-gamma by mouse dendritic cell subsets. J Immunol 2001, 166:5448-5455.
21. Mason N, Aliberti J, Caamano JC, et al.: Cutting edge: identification of c-Rel-dependent and -independent pathways of IL-12 production during infectious and inflammatory stimuli. J Immunol 2002, 168:2590-2594.
22. Cheng G, Cleary AM, Ye ZS, et al.: Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 1995, 267:1494-1498.
23. Rothe M, Sarma V, Dixit VM, et al.: TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 1995, 269:1424-1427.
24. Ishida TK, Tojo T, Aoki T, et al.: TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc Natl Acad Sci U S A 1996, 93:9437-9442.
25. Ishida T, Mizushima S, Azuma S, et al.: Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J Biol Chem 1996, 271:26745-26748.
26. Tsukamoto N, Kobayashi N, Azuma S, et al.: Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40. Proc Natl Acad Sci U S A 1999, 96:1234-1239.
27. Pullen SS, Dang TT, Crute JJ, et al.: CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs): binding site specificity and activation of downstream pathways by distinct TRAFs. J Biol Chem 1999, 274:14246-14254.
28. Leo E, Welsh K, Matsuzawa S, et al.: Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation. J Biol Chem 1999, 274:22414-22422.
29. Aicher A, Shu GL, Magaletti D, et al.: Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells. J Immunol 1999, 163:5786-5795.
30. Hanissian SH, Geha RS: Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 1997, 6:379-387.
31. Karras JG, Wang Z, Huo L, et al.: Induction of STAT protein signaling through the CD40 receptor in B lymphocytes: distinct STAT activation following surface Ig and CD40 receptor engagement. J Immunol 1997, 159:4350-4355.
32. Ghosh S, May MJ, Kopp EB: NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998, 16:225-260.
33. Garceau N, Kosaka Y, Masters S, et al.: Lineage-restricted function of nuclear factor kappaB-inducing kinase (NIK) in transducing signals via CD40. J Exp Med 2000, 191:381-386.
34. O'Sullivan BJ, Thomas R: CD40 Ligation conditions dendritic cell antigen-presenting function through sustained activation of NF-kappaB. J Immunol 2002, 168:5491-5498. Demonstrates that NFκB activation is essential for T-cell activation by dendritic cells, and T-cell function is enhanced if dendritic cell NFκB activation is prolonged. Sustained NFκB activation can be achieved by blocking interleukin-10 in the presence of stimuli that induce tumor necrosis factor-α.
35. Ardeshna KM, Pizzey AR, Devereux S, et al.: The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood 2000, 96:1039-1046.
36. Ammon C, Mondal K, Andreesen R, et al.: Differential expression of the transcription factor NK-kappa B during human mononuclear phagocyte differentiation to macrophages and dendritic cells. Biochem Biophys Res Commun 2000, 268:99-105.
37. Arrighi JF, Rebsamen M, Rousset F, et al.: A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaocharide, TNF-alpha, and contact sensitizers. J Immunol 2001, 166:3837-3845.
38. Hofer S, Rescigno M, Granucci F, et al.: Differential activation of NF-kappa B subunits in dendritic cells in response to Gram-negative bacteria and to lipopolysaccharide. Microbes Infect 2001, 3:259-265.
39. Lyakh LA, Koski GK, Telford W, et al.: Bacterial lipopolysaccharide, TNF-alpha, and calcium ionophore under serum-free conditions promote rapid dendritic cell-like differentiation in CD14+ monocytes through distinct pathways that activate NK-kappa B. J Immunol 2000, 165:3647-3655.
40. Neumann M, Fries H, Scheicher C, et al.: Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood 2000, 95:277-285.
41. Brossart P, Zobywalski A, Grunebach F, et al.: Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells. Cancer Res 2000, 60:4485-4492.
42. Yoshimura S, Bonderson J, Brennan FM, et al.: Role of NF-kappaB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with protease inhibitor PSI. Eur J Immunol 2001, 31:1883-1893.
43. Burkly L, Hession C, Ogata L, et al.: Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 1995, 373:531-536.
44. DiMolfetto L, Reilly C, Wei Q, et al.: Dendritic-like cells from relB mutant mice. Adv Exp Med Biol 1997, 417:47-54.
45. Weih F, Warr G, Yang H, et al.: Multifocal defects in immune responses in RelB-deficient mice. J Immunol 1997, 158:5211-5218.
46. Ouaaz F, Arron J, Zheng Y, et al.: Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 2002, 16:257-270. Demonstrates essential, subunit-specific functions for the NFKB proteins c-Rel, RelA, and p50 in regulating dendritic cell development, survival, and cytokine production.
47. Martin E, O'Sullivan BJ, Low P, et al.: Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity 2003, 18:155-167. Demonstrates essential subunit-specific functions for NFKB protein RelB in regulating dendritic cell expression of CD40 and inducing tolerance.
48. Tone M, Tone Y, Babik JM, et al.: The role of Sp1 and NF-kappa B in regulating CD40 gene expression. J Biol Chem 2002, 277:8890-8897.
49. Bouchon A, Hernandez-Munain C, Cella M, et al.: A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med 2001, 194:1111-1122.
50. Tone M, Tone Y, Fairchild PJ, et al.: Regulation of CD40 function by its isoforms generated through alternative splicing. Proc Natl Acad Sci U S A 2001, 98:1751-1756.
51. Colotta F, Dower SK, Sims JE, et al.: The type II "decoy" receptor: a novel regulatory pathway for interleukin 1. Immunol Today 1994, 15:562-566.
52. Orlando S, Matteucci C, Fadlon EJ, et al.: TNF-alpha, unlike other pro- and anti-inflammatory cytokines, induces rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells. J Immunol 1997, 158:3861-3868.
53. Mantovani A, Locati M, Vecchi A, et al.: Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol 2001, 22:328-336.
54. Dejardin E, Deregowski V, Greimers R, et al.: Regulation of major histocompatibility complex class I expression by NF-kappaB-related proteins in breast cancer cells. Oncogene 1998, 16:3299-3307.
55. O'Sullivan BJ, MacDonald KP, Pettit AR, et al.: RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function. Proc Natl Acad Sci U S A 2000, 97:11421-11426.
56. Groux H, O'Garra A, Bigler M, et al.: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389:737-742.
57. Gilliet M, Liu YJ: Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 2002, 195:695-704.
58. Cobbold S, Waldmann H: Infectious tolerance. Curr Opin Immunol 1998, 10:518-524.
59. Hanninen A, Martinez NR, Davey GM, et al.: Transient blockade of CD40 ligand dissociates pathogenic from protective mucosal immunity. J Clin Invest 2002, 109:261-267.
60. Gao JX, Madrenas J, Zeng W, et al.: CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection. Immunology 1999, 98:159-170.
61. Taylor PA, Friedman TM, Korngold R, et al.: Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell. Blood 2002, 99:4601-4609.
62. Ozaki ME, Coren BA, Huynh TN, et al.: CD4+ T cell responses to CD40-deficient APCs: defects in proliferation and negative selection apply only with B cells as APCs. J Immunol 1999, 163:5250-5256.
63. Shimizu K, Schonbeck U, Mach F, et al.: Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J Immunol 2000, 165:3506-3518.
64. Urban BC, Ferguson DJ, Pain A, et al.: Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 1999, 400:73-77.
65. Butcher BA, Kim L, Johnson PF, et al.: Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-kappa B. J Immunol 2001, 167:2193-2201.
66. Andrews DM, Andoniou CE, Granucci F, et al.: Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol 2001, 2:1077-1084.
67. Hahn G, Jores R, Mocarski ES: Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A 1998, 95:3937-3942.
68. Moutaftsi M, Mehl AM, Borysiewicz LK, et al.: Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 2002, 99:2913-2921.